Clinical Trial Update: Intravenous Ondansetron to Attenuate the Hypotensive, Bradycardic Response to Spinal Anesthesia in Healthy Parturients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating intravenous ondansetron to reduce hypotension and bradycardia during spinal anesthesia in healthy pregnant individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypotension
• Pregnancy

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

Sponsor: University of Virginia | Conditions: Hypotension, Pregnancy | Phase 2, Phase 3 | Status: COMPLETED